Literature DB >> 11808943

Mortality from hepatocellular and biliary cancers: changing epidemiological trends.

Satheesh Nair1, K Shiv Kumar, Paul J Thuluvath, K S Shivakumar, K Shiva Kumar.   

Abstract

OBJECTIVES: The incidence of hepatocellular carcinoma may be rising in the United States. The aim of this study was to determine the epidemiological trends in mortality from hepatocellular carcinoma (HCC) and biliary cancers (BCs) in Maryland during the last 3 decades.
METHODS: The number of deaths due to HCC and BCs from 1970 to 1997 were obtained from the Maryland State Department of Health & Hygiene vital statistics database. Malignant neoplasms of the gallbladder and intrahepatic and extrahepatic bile ducts were grouped together as biliary cancers. To determine the trend in mortality, the total time period was divided into seven 4-yr periods.
RESULTS: Mortality from HCC increased from 0.94 to 1.84 per 100,000 population (rate ratio = 1.94, CI = 1.87-2.03) and that from BCs increased from 1.28 to 1.7 per 100,000 population (rate ratio = 1.31, CI = 1.26-1.36) over the study period. Although mortality due to HCC doubled in men (1.34 to 2.7 per 100,000) during this period, only a modest increase was observed among women (0.59 to 1.06 per 100,000). Because of a marked increase in the number of deaths among white Americans, the difference in HCC-related mortality between white Americans and African Americans decreased considerably during this period. Mean age at death increased steadily for BCs from 67 to 73 yr, whereas there was no real trend for HCC. Among African Americans, the death from HCC remained stable, but there was a 2-fold increase in BC-related death.
CONCLUSIONS: There was a marked increase in deaths from HCC over the past 3 decades in Maryland. This increase was more evident among men and white Americans. Deaths due to BCs increased modestly during the same period of observation. The marked rise in BC-related deaths among African Americans remains unexplained.

Entities:  

Mesh:

Year:  2002        PMID: 11808943     DOI: 10.1111/j.1572-0241.2002.05432.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  10 in total

1.  The prevalence of hepatitis C virus infection in Texas: implications for future health care.

Authors:  Kanthi Yalamanchili; Sherif Saadeh; Rita Lepe; Gary L Davis
Journal:  Proc (Bayl Univ Med Cent)       Date:  2005-01

2.  Differences in characteristics of patients with and without known risk factors for hepatocellular carcinoma in the United States.

Authors:  Jon D Dorfman; Richard Schulick; Michael A Choti; Jean-Francois H Geschwind; Ihab Kamel; Michael Torbenson; Paul J Thuluvath
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

Review 3.  Photodynamic therapy for pancreatic and biliary tract carcinoma.

Authors:  Lakshmana Ayaru; Stephen G Bown; Stephen P Pereira
Journal:  Int J Gastrointest Cancer       Date:  2005

4.  Slug inhibition upregulates radiation-induced PUMA activity leading to apoptosis in cholangiocarcinomas.

Authors:  Kejun Zhang; Bingyuan Zhang; Yun Lu; Chuandong Sun; Wei Zhao; Xuelong Jiao; Jilin Hu; Peng Mu; Hai Lu; Changyong Zhou
Journal:  Med Oncol       Date:  2010-12-01       Impact factor: 3.064

5.  A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades.

Authors:  Yasuhito Tanaka; Kousuke Hanada; Masashi Mizokami; Anthony E T Yeo; J Wai-Kuo Shih; Takashi Gojobori; Harvey J Alter
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-18       Impact factor: 11.205

6.  MRI versus 64-row MDCT for diagnosis of hepatocellular carcinoma.

Authors:  Michael Bernhard Pitton; Roman Kloeckner; Sascha Herber; Gerd Otto; Karl Friedrich Kreitner; Christoph Dueber
Journal:  World J Gastroenterol       Date:  2009-12-28       Impact factor: 5.742

7.  Natural History and Prognostic Factors of Advanced Cholangiocarcinoma without Surgery, Chemotherapy, or Radiotherapy: A Large-Scale Observational Study.

Authors:  Jongha Park; Myung-Hwan Kim; Kyu-Pyo Kim; Do Hyun Park; Sung-Hoon Moon; Tae Jun Song; Junbum Eum; Sang Soo Lee; Dong Wan Seo; Sung Koo Lee
Journal:  Gut Liver       Date:  2009-12-31       Impact factor: 4.519

Review 8.  The epidemiology of hepatitis C infection in the United States.

Authors:  Vinod K Rustgi
Journal:  J Gastroenterol       Date:  2007-07-25       Impact factor: 7.527

9.  DNA adducts, detected by 32P postlabelling, in human cholangiocarcinoma.

Authors:  S A Khan; P L Carmichael; S D Taylor-Robinson; N Habib; H C Thomas
Journal:  Gut       Date:  2003-04       Impact factor: 23.059

10.  Clinical Significance of Plasma Osteopontin Level as a Biomarker of Hepatocellular Carcinoma.

Authors:  Mona Salem; Sahar Abdel Atti; Maisa El Raziky; Samar Kamal Darweesh; Marwa El Sharkawy
Journal:  Gastroenterology Res       Date:  2013-10-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.